Inspire Investing LLC Acquires 1,995 Shares of The Chemours Company (NYSE:CC)

Inspire Investing LLC boosted its holdings in shares of The Chemours Company (NYSE:CC) by 14.6% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 15,618 shares of the specialty chemicals company’s stock after buying an additional 1,995 shares during the quarter. Inspire Investing LLC’s holdings in Chemours were worth $352,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of CC. New Covenant Trust Company N.A. acquired a new stake in shares of Chemours during the 1st quarter worth about $29,000. North Star Investment Management Corp. lifted its position in Chemours by 1,510.0% during the first quarter. North Star Investment Management Corp. now owns 1,288 shares of the specialty chemicals company’s stock worth $34,000 after acquiring an additional 1,208 shares during the last quarter. Sunbelt Securities Inc. boosted its holdings in shares of Chemours by 1,969.7% during the first quarter. Sunbelt Securities Inc. now owns 1,366 shares of the specialty chemicals company’s stock worth $36,000 after acquiring an additional 1,300 shares during the period. Neo Ivy Capital Management acquired a new position in shares of Chemours in the fourth quarter valued at approximately $40,000. Finally, Headlands Technologies LLC bought a new position in shares of Chemours during the first quarter worth approximately $42,000. Institutional investors own 76.26% of the company’s stock.

Chemours Stock Performance

NYSE CC opened at $18.70 on Monday. The firm’s 50 day simple moving average is $20.05 and its 200 day simple moving average is $23.88. The firm has a market capitalization of $2.78 billion, a price-to-earnings ratio of -8.62 and a beta of 1.74. The company has a current ratio of 1.89, a quick ratio of 1.01 and a debt-to-equity ratio of 5.45. The Chemours Company has a 1 year low of $15.10 and a 1 year high of $32.70.

Chemours (NYSE:CC) last issued its quarterly earnings results on Thursday, August 1st. The specialty chemicals company reported $0.38 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.57 by ($0.19). Chemours had a net margin of 2.16% and a return on equity of 33.21%. The business had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.53 billion. During the same quarter in the previous year, the business posted $1.10 EPS. The company’s revenue for the quarter was down 6.4% on a year-over-year basis. As a group, research analysts expect that The Chemours Company will post 1.33 earnings per share for the current fiscal year.

Chemours Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, September 13th. Shareholders of record on Thursday, August 15th were paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 5.35%. The ex-dividend date was Thursday, August 15th. Chemours’s payout ratio is -46.08%.

Analysts Set New Price Targets

CC has been the topic of a number of research reports. The Goldman Sachs Group decreased their price objective on Chemours from $29.00 to $23.00 and set a “neutral” rating on the stock in a report on Tuesday, September 3rd. Mizuho initiated coverage on shares of Chemours in a research note on Friday, June 7th. They issued a “neutral” rating and a $25.00 price target on the stock. JPMorgan Chase & Co. dropped their price objective on shares of Chemours from $25.00 to $18.00 and set a “neutral” rating for the company in a research note on Tuesday, August 6th. UBS Group decreased their target price on shares of Chemours from $30.00 to $28.00 and set a “buy” rating on the stock in a research report on Tuesday, August 6th. Finally, Barclays dropped their price target on shares of Chemours from $30.00 to $22.00 and set an “equal weight” rating for the company in a research report on Tuesday, August 6th. Six equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, Chemours presently has a consensus rating of “Hold” and a consensus target price of $26.75.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.